Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 14/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | JAK1 | P23458 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | WEE1 | P30291 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17849188 | 0.90 | EGFR (0.40) | EGFRALDH1A1JAK2JAK1MAOB | |
| SCHEMBL16623503 | 0.87 | EGFR (0.35) | EGFRJAK2JAK1 | |
| SCHEMBL17849221 | 0.85 | EIF2AK2 (0.34) | EGFRJAK2JAK1 | |
| SCHEMBL17849248 | 0.85 | EGFR (0.41) | EGFRALDH1A1JAK2JAK1 | |
| SCHEMBL16623568 | 0.84 | EGFR (0.38) | EGFRJAK2JAK1 | |
| SCHEMBL16623565 | 0.82 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL17849244 | 0.82 | TYK2 (0.40) | EGFRALDH1A1HSD17B10JAK2JAK1 | |
| SCHEMBL18052623 | 0.82 | EGFR (0.36) | EGFRKDRJAK2JAK1 | |
| SCHEMBL17849247 | 0.81 | MAPT (0.41) | EGFRALDH1A1MAOB | |
| SCHEMBL16623558 | 0.81 | PARP1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371320-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9371320-B2 | Heterocyclic compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-06-21 | — | — | US | disclosed |